Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanglaite Injection for cancer cachexia
ChiCTR-IPR-15006792Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Mar 2015
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of kanglaite in cancer anorexia-cachexia syndrome (CACS) (2 arms), sponsored by Tongji Hospital. Primary endpoints: Body weight and Lean body mass. Planned start Mar 2015; status: not yet recruiting.
02
Drugs
kanglaite
03
Conditions
cancer anorexia-cachexia syndrome (CACS)
Beyond the preview
Go deeper on ChiCTR-IPR-15006792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006792.